Chronos Archive seal

Review checklist: Lou Gehrig (HR-ET018)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the mimic work-up, the EMG criteria (Gold Coast and revised El Escorial), riluzole liver monitoring, the decisions on edaravone and tofersen, the noninvasive ventilation thresholds, gastrostomy timing, and work accommodation.
provenance reviewnot_startedThe SABR biography (Ray), two National Baseball Hall of Fame articles, and PBS NewsHour (Markel 2016) logged. The death date conflict (June 2 or 3, 1941) and the head-trauma hypothesis (R, disputed) are recorded.
safe messaging reviewnot_startedA progressive fatal illness: the modern episode screens mood at every visit (PHQ-9 below 10 throughout) and plans care early; his documented speech is quoted only as history; no decision, statement or health fact is attributed to his wife or other real people.

Judgment calls (dossier editorial resolutions)

  1. Recent-death rule. He died in 1941, so the rule does not apply. Every historical claim is limited to what the fetched sources state.
  2. Name. The record uses “Lou Gehrig” and “Mr. Gehrig.” The alias “Henry Louis Gehrig” (SABR) appears in no other record. The nickname “The Iron Horse” was not found in a fetched source and is not used.
  3. Index age and dates. The synthetic date of birth is June 19, 1990 (shift 87 years). The index visit on May 4, 2026 maps to May 4, 1939, two days after he took himself out of the lineup in Detroit (CLM-0004), when he was 35, about a year after his first symptoms (CLM-0011). The visits on May 18, June 29, August 24 and October 19, 2026, the sick visit on July 20, 2026, and the preventive visit on September 21, 2026 map to the same days of 1939; none falls on his Mayo Clinic stay of June 13 to 19 or on July 4, 1939, and all fall well within his lifetime. The modern diagnosis is made on May 18, about a month earlier than the documented diagnosis on June 19, 1939; the timing, EMG findings, test results, scores and treatment are synthetic. He is 36 at the preventive visit, so it is a periodic adult preventive visit (preventive_adult).
  4. Presenting problem. Progressive weakness and loss of coordination (M62.81) is the presenting problem at intake, resolved at the consultation on May 18, 2026, when ALS (G12.21) was diagnosed. It is anchored to the documented decline in 1938 and 1939 (CLM-0004, CLM-0005, CLM-0011). The intake documents state only what was known then: the suspicion of a motor neuron disorder and the mimic work-up. Riluzole, genetic testing, the ALS clinic and the respiratory plan are dated to the consultation; nutrition, speech, mobility and work planning to the visit six weeks later.
  5. Death date. SABR (with the time, 10:10 p.m.) and the Hall of Fame give June 2, 1941; PBS gives June 3. June 2 is used and June 3 is recorded as a conflicting alternative.
  6. Head trauma hypothesis. The PBS essay reports repeated head injuries, including concussions (CLM-0012, D, probable; recorded in the past medical history), and the suggestion that repetitive head trauma can mimic ALS (CLM-0010, R, disputed). The modern episode records a synthetic history of concussions without lasting symptoms, and the consultant states that they do not change the diagnosis or treatment. The sealed Mayo records are noted; no autopsy finding is claimed.
  7. Work and the Parole Commission. His documented acceptance of a Parole Commission appointment in October 1939 (CLM-0008) and the Mayo statement that he could continue in some executive activity (CLM-0006) anchor the modern work-accommodation theme: a desk role in city public service, started two weeks before the last visit, with accommodations. These claims describe events after the true-frame index date and appear only in later documents.
  8. Real people. His parents and siblings appear only in the claims and the family history (D). Harold C. Habein and Mayor La Guardia appear only in documented history. His wife is not named in the claims; his modern wife is unnamed and has no role, and his health care agent is not named. No modern decision, statement or health fact is attributed to any real person. His July 4, 1939 speech is quoted once, as history, from the Hall of Fame.
  9. Mood and safety. PHQ-9 scores stay between 6 and 8 (mild) with no thoughts of self-harm, and PHQ-2 is 1; no behavioral-health diagnosis is coded, so no safety assessment is required. Mood is screened at every visit and psychology is offered, as the AAN parameters advise.
  10. Sick visit. A same-day visit for a left lateral ankle sprain (S93.402A) after tripping on a curb on a day he did not wear his ankle-foot orthosis, chosen because foot drop makes falls an expected risk in ALS, it insinuates no undocumented real diagnosis, and it interacts with the case: the Ottawa rules spare an X-ray, the orthosis plan is reinforced, and the two-month riluzole liver test is drawn. Treated with a brace and a five-day course of ibuprofen.
  11. Preventive visit. A periodic adult preventive visit at age 36 (CPT 99395 and 99497 in plain text): influenza and COVID-19 vaccines (neuromuscular disease raises the risk from respiratory infection), hepatitis B screening with the HepB-CpG series started (second dose at the last visit), a hepatitis C test (negative), HIV already tested at intake, diabetes screening up to date, colorectal screening not yet due, pneumococcal vaccine judged not indicated at his age on the CDC risk-condition list and flagged for review as breathing weakens, and early advance care planning with an unnamed agent.
  12. Focused visits. The four chronic-care follow-ups (the consultation day, six weeks, three months and five months after diagnosis) are documented as focused visits on the AAN ALS practice parameters (2009), the Gold Coast and revised El Escorial criteria, the ALS genetic testing guideline, and riluzole liver monitoring. One protocol deviation is recorded: the one-month ALT on riluzole was missed because no visit fell then; ALT was normal at six weeks (38 U/L), so no harm resulted, and the two- and three-month tests were booked (41 U/L at the sick visit and 35 U/L at three months). Noninvasive ventilation criteria were not met by the last visit (FVC 72% seated and 63% supine, maximal inspiratory pressure -62 cmH2O); overnight oximetry was ordered. The supine FVC and maximal inspiratory pressures are narrative only.
  13. Consultation. The neuromuscular neurology referral and the consultation by Priscilla Nakamura, MD (a fictional consultant), with EMG and nerve conduction studies on the same day, are S. The consultant answers the five referral questions in line with what the record shows afterwards: ALS with mimics excluded; the EMG findings and the Gold Coast and revised El Escorial criteria; riluzole (started), genetic testing (no SOD1 variant, so no tofersen), edaravone discussed and deferred by him; the monitoring and intervention thresholds (followed at each visit); and work, mood and planning support (accommodations, psychology, advance care planning).
  14. Synthetic content. All visits, laboratory values, imaging, EMG and nerve conduction findings, genetic results, vital signs, spirometry, ALSFRS-R, PHQ-2, PHQ-9 and AUDIT-C scores, the medicines and doses, his height (183 cm), and his modern household are synthetic. Qualitative results (MRI, EMG and nerve conduction studies, protein electrophoresis, HIV, hepatitis B and C tests, genetic panel, maximal inspiratory pressure, supine FVC) appear only in the note text.
  15. Not used. Mayo Clinic records (sealed), the full Habein letter (the Hall of Fame collection page could not be reached), his wife’s memoir, and accounts of experimental treatments he may have received were not fetched and are not used.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-06-29
Progress note 03 (C-CDA)
ALT on riluzoleMonthly for 3 months, then every 3 monthsMissed: no liver test was drawn at one month because no visit fell then. ALT 38 U/L today, at six weeks, is normal, so no harm resulted. Corrective action: two- and three-month tests booked with the ALS clinic laboratory

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-05-18
Progress note 02 (C-CDA)
LaboratoryGenetic testing (SOD1 result decides tofersen)OrderedPanel sent today after genetic counseling
2026-09-21
Progress note 06 (C-CDA)
PreventionHepatitis C screeningOrderedNever tested; once-in-a-lifetime antibody test drawn today
2026-10-19
Progress note 07 (C-CDA)
ExaminationMaximal inspiratory pressure; supine capacity and overnight oximetry when values fall or symptoms appearOrderedMaximal inspiratory pressure -62 cmH2O; supine FVC 63%; overnight oximetry ordered
2026-10-19
Progress note 07 (C-CDA)
ExaminationSpeech and swallowing assessmentOrderedMild to moderate dysarthria; cough with thin liquids; swallowing study ordered

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0010Researchers at the Boston University center for the study of traumatic encephalopathy have suggested that repetitive head trauma can cause a syndrome that mimics ALS, and that his repeated head injuries may have contributed to his decline; the Mayo Clinic has sealed his records, and it is not known whether an autopsy was performed.disputed

Sensitive claims

None.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-05-04Creatine kinase412 U/L (high)High
2026-08-24Forced vital capacity (seated)4.05 L (low)Low
2026-08-24Forced vital capacity, percent predicted (seated)79% (low)Low
2026-10-19Forced vital capacity (seated)3.69 L (low)Low
2026-10-19Forced vital capacity, percent predicted (seated)72% (low)Low